Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lode

Showing results (131-140 of 369) with videos related to

Pageof 37
Sort By:
Nephron|January 1, 1982
Supplementary dose after hemodialysisF Keller, G Offermann, H Lode
Deutsche Medizinische Wochenschrift (1946)|June 30, 1972
[Generalized so-called idiopathic amyloidosis. Clinical and pathologic-anatomical aspects]H Lode, R Dreher, U Klemens
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Oral antibiotic therapy in gastrectomized patients]H Lode, D Frisch, P Naumann
Antimicrobial Agents and Chemotherapy|July 1, 1979
Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000H Lode, R Stahlmann, P Koeppe
Arzneimittel-Forschung|February 1, 1973
[Combination therapy using penicillin. Methods of analysis and pharmacokinetics of oxacillin and ampicillin administered simultaneously]P Naumann, H Lode, E Reintjens
Arzneimittel-Forschung|October 1, 1972
[The effect of oral by administered theophylline on specific airway resistance in airway obstruction]H Lode, U Hüttemann, H Huckauf
Advances in Clinical Pharmacology|January 1, 1974
[Clinical pharmacology of three ampicillins and amoxicillin by oral application]H Lode, P Janisch, G Küpper
The European Respiratory Journal|October 1, 1996
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosisT Schaberg, K Rebhan, H Lode
Chemotherapy|January 1, 1975
Comparative pharmacokinetics and clinical experience with a new cephalosporin-derivative: cefazolinH Lode, S Gebert, A Hendrischk
Journal of Chromatography. A|July 27, 1999
Determination of trovafloxacin in human body fluids by high-performance liquid chromatographyK Borner, H Hartwig, H Lode
Pageof 37

Showing results (131-140 of 369) with videos related to

Sort By:
Pageof 37
Nephron|January 1, 1982
Supplementary dose after hemodialysisF Keller, G Offermann, H Lode
Deutsche Medizinische Wochenschrift (1946)|June 30, 1972
[Generalized so-called idiopathic amyloidosis. Clinical and pathologic-anatomical aspects]H Lode, R Dreher, U Klemens
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Oral antibiotic therapy in gastrectomized patients]H Lode, D Frisch, P Naumann
Antimicrobial Agents and Chemotherapy|July 1, 1979
Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000H Lode, R Stahlmann, P Koeppe
Arzneimittel-Forschung|February 1, 1973
[Combination therapy using penicillin. Methods of analysis and pharmacokinetics of oxacillin and ampicillin administered simultaneously]P Naumann, H Lode, E Reintjens
Arzneimittel-Forschung|October 1, 1972
[The effect of oral by administered theophylline on specific airway resistance in airway obstruction]H Lode, U Hüttemann, H Huckauf
Advances in Clinical Pharmacology|January 1, 1974
[Clinical pharmacology of three ampicillins and amoxicillin by oral application]H Lode, P Janisch, G Küpper
The European Respiratory Journal|October 1, 1996
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosisT Schaberg, K Rebhan, H Lode
Chemotherapy|January 1, 1975
Comparative pharmacokinetics and clinical experience with a new cephalosporin-derivative: cefazolinH Lode, S Gebert, A Hendrischk
Journal of Chromatography. A|July 27, 1999
Determination of trovafloxacin in human body fluids by high-performance liquid chromatographyK Borner, H Hartwig, H Lode
Pageof 37